Clinical Trials Directory

Trials / Conditions / MDR-TB

MDR-TB

11 registered clinical trials studyying MDR-TB — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingFeasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Pati
NCT07486024
Assistance Publique - Hôpitaux de ParisPhase 3
Not Yet RecruitingAcetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)
NCT07393438
Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 2
CompletedHIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes
NCT06671808
Zahedan University of Medical Sciences—
RecruitingA Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
NCT05493267
Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 4
CompletedTriage Test for All Oral DR-TB Regimen (TRiAD Study)
NCT05175794
Centre for the AIDS Programme of Research in South Africa—
CompletedA Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
NCT05278988
Shanghai Pulmonary Hospital, Shanghai, ChinaPhase 4
CompletedSaliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania
NCT04124055
Jan-Willem C AlffenaarN/A
CompletedTuberculosis Research of INA-RESPOND On Drug Resistance
NCT02758236
Ina-Respond—
CompletedThe Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
NCT02409290
IUATLD, IncPhase 3
Active Not RecruitingA Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
NCT02129244
Johns Hopkins UniversityN/A
UnknownStudy of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB
NCT03069534
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2 / Phase 3